Mario Gabelli Lantheus Holdings, Inc. Transaction History

Gamco Investors, Inc. Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$23.33 - $28.3 $465,456 - $564,613	-19,951 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$14.93 - $25.1 $597,200 - $1 Million	-40,000 Reduced 66.72%	19,951 $488,000
Q4 2018 Jan 30, 2019	BUY	$12.68 - $19.01 $126,800 - $190,100	10,000 Added 20.02%	59,951 $938,000
Q3 2018 Nov 02, 2018	BUY	$13.1 - $16.35 $454,570 - $567,345	34,700 Added 227.53%	49,951 $747,000
Q2 2018 Aug 10, 2018	BUY	$13.65 - $18.7 $208,176 - $285,193	15,251 New	15,251 $222,000

443

65.1M

1.47M

771K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.4B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.